Physician profile
Michael E Freeman
NPI 1740240993
$808.08
in general payments reported to CMS, 2019-2025
13 companies · $18.55 in 2025
The $18.55 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.48 · 2020: $109 · 2021: $279 · 2022: $202 · 2023: $65.74 · 2024: $34.30 · 2025: $18.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $203.06 | 2021-2024 | Monovisc |
| Bioventus LLC | $129.42 | 2021-2022 | |
| Pacira Therapeutics, INC. | $127.43 | 2019-2021 | |
| Medical Device Business Services, INC. | $77.52 | 2022 | |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Endo Pharmaceuticals INC. | $44.02 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $38.69 | 2019 | |
| Smith+Nephew, INC. | $33.97 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.20 | 2021 | |
| Ossur Americas, INC. | $18.55 | 2025 | |
| Next Science LLC | $14.48 | 2021 | |
| Horizon Therapeutics Plc | $13.41 | 2019 | |
| Radius Health, INC. | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.